Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
56%(5 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_1
1
9%
Ph phase_2
1
9%
Ph phase_4
5
45%
Ph phase_3
4
36%

Phase Distribution

1

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
4(36.4%)
Phase 4Post-market surveillance
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(2)

Detailed Status

Completed9
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 21 (9.1%)
Phase 34 (36.4%)
Phase 45 (45.5%)

Trials by Status

completed982%
terminated218%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_4

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

NCT00070707
completedphase_4

Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

NCT00783237
completedphase_4

Elocon vs Fluticasone in Localized Psoriasis (P03197)

NCT00763529
completedphase_3

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

NCT05311475
completedphase_2

Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2

NCT03758950
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00070707Phase 4

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Completed
NCT00783237Phase 4

Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

Completed
NCT00763529Phase 4

Elocon vs Fluticasone in Localized Psoriasis (P03197)

Completed
NCT05311475Phase 3

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

Completed
NCT03758950Phase 2

Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2

Completed
NCT00783224Phase 3

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)

Completed
NCT00461812Phase 4

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

Terminated
NCT02154334Phase 1

Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine

Completed
NCT02541760Phase 3

Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children

Completed
NCT00361439Phase 4

Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

Terminated
NCT01401465Phase 3

Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11